SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-135413
Filing Date
2016-11-18
Accepted
2016-11-18 17:03:30
Documents
64
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v452759_10q.htm 10-Q 362458
2 EXHIBIT 31.1 v452759_ex31-1.htm EX-31.1 10648
3 EXHIBIT 31.2 v452759_ex31-2.htm EX-31.2 10657
4 EXHIBIT 32.1 v452759_ex32-1.htm EX-32.1 5307
5 EXHIBIT 32.2 v452759_ex32-2.htm EX-32.2 5428
  Complete submission text file 0001144204-16-135413.txt   4032027

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ibio-20160930.xml EX-101.INS 857133
7 XBRL TAXONOMY EXTENSION SCHEMA ibio-20160930.xsd EX-101.SCH 40119
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ibio-20160930_cal.xml EX-101.CAL 33521
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ibio-20160930_def.xml EX-101.DEF 287887
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ibio-20160930_lab.xml EX-101.LAB 295968
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ibio-20160930_pre.xml EX-101.PRE 319357
Mailing Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35023 | Film No.: 162008445
SIC: 2834 Pharmaceutical Preparations